- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
A novel strategy for l-arginine production in engineered Escherichia coli ; volume:22 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-13 ; date:12.2023
Microbial cell factories ; 22, Heft 1 (26.7.2023), 1-13, 12.2023
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Nie, Mengzhen
Wang, Jingyu
Zhang, Kechun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12934-023-02145-8
- URN
-
urn:nbn:de:101:1-2023102710154893055331
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nie, Mengzhen
- Wang, Jingyu
- Zhang, Kechun
- SpringerLink (Online service)
Other Objects (12)
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm